BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
251 hedge funds and large institutions have $1.5B invested in BioTelemetry, Inc. in 2019 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 111 increasing their positions, 71 reducing their positions, and 90 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 71
19% less funds holding
Funds holding: 311 → 251 (-60)
23% less capital invested
Capital invested by funds: $1.94B → $1.5B (-$444M)
48% less call options, than puts
Call options by funds: $12.1M | Put options by funds: $23.3M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
61% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 90
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$105M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$10.9M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$10.6M |
| 4 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
+$10.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$47.7M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$33.2M |
| 3 |
AI
Atria Investments
Charlotte,
North Carolina
|
-$22M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$14.6M |
| 5 |
N
Natixis
Paris,
France
|
-$13.9M |
BEAT Hedge Fund Activity: Q2 2019 in Review
251 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q2 2019, worth a combined $1.5B — down 23% from $1.94B a quarter earlier.
Sellers outnumbered buyers: 90 funds closed out of BEAT and 35 opened new positions — a net loss of 55 holders — while 71 trimmed existing stakes and 111 added.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $105M. The largest seller was Macquarie Group, exiting entirely with an estimated $47.7M sold.
- 251 institutional investors held BioTelemetry, Inc. (BEAT) as of Q2 2019, down from 311 in Q1 2019.
- Funds reported $1.5B of BioTelemetry, Inc. stock for Q2 2019, down 23% quarter-over-quarter.
- 35 funds opened new BioTelemetry, Inc. positions in Q2 2019 and 90 closed out, a net change of -55 holders.
- The largest BioTelemetry, Inc. buyer in Q2 2019 was ArrowMark Colorado Holdings, an estimated $105M added.
- The largest BioTelemetry, Inc. seller in Q2 2019 was Macquarie Group, an estimated $47.7M sold.
Based on aggregated 13F filings for Q2 2019.